The immunological life cycle of tuberculosis
- PMID: 22790178
- DOI: 10.1038/nri3259
The immunological life cycle of tuberculosis
Abstract
Immune responses to Mycobacterium tuberculosis are only partially effective; they drive the bacteria into a latent state, but rarely eliminate them. Unfortunately, the latent state of M. tuberculosis is reversible, and reactivation tuberculosis is the source of most transmission. Studies in animal models and in humans have not yet yielded a comprehensive picture of the mechanisms or correlates of immunity to M. tuberculosis infection, or of why immunity fails to eradicate the pathogen. This Review proposes that there are distinct stages in the immune response to M. tuberculosis that form an 'immunological life cycle'. It is hoped that this thesis will provide a framework for investigation to understand immunity to M. tuberculosis and to guide tuberculosis vaccine discovery and development.
Similar articles
-
[Immune response to Mycobacterium tuberculosis].Internist (Berl). 2016 Feb;57(2):107-16. doi: 10.1007/s00108-015-0016-4. Internist (Berl). 2016. PMID: 26838368 Review. German.
-
Trained innate immunity and resistance to Mycobacterium tuberculosis infection.Clin Microbiol Infect. 2019 Dec;25(12):1468-1472. doi: 10.1016/j.cmi.2019.02.015. Epub 2019 Feb 23. Clin Microbiol Infect. 2019. PMID: 30807849 Review.
-
Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against Mycobacterium tuberculosis Infection.Front Immunol. 2019 Jan 16;9:3190. doi: 10.3389/fimmu.2018.03190. eCollection 2018. Front Immunol. 2019. PMID: 30700988 Free PMC article.
-
Natural and trained innate immunity against Mycobacterium tuberculosis.Immunobiology. 2020 May;225(3):151951. doi: 10.1016/j.imbio.2020.151951. Epub 2020 Apr 27. Immunobiology. 2020. PMID: 32423788 Review.
-
Reflections on the immunology of tuberculosis: will we ever unravel the skein?BMC Infect Dis. 2014;14 Suppl 1(Suppl 1):S1. doi: 10.1186/1471-2334-14-S1-S1. Epub 2014 Jan 8. BMC Infect Dis. 2014. PMID: 24564297 Free PMC article. Review.
Cited by
-
Persistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challenge.Curr HIV/AIDS Rep. 2015 Mar;12(1):107-16. doi: 10.1007/s11904-015-0256-x. Curr HIV/AIDS Rep. 2015. PMID: 25772785 Free PMC article. Review.
-
Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology.Am J Clin Exp Immunol. 2013 Feb 27;2(1):124-34. Print 2013. Am J Clin Exp Immunol. 2013. PMID: 23885330 Free PMC article.
-
IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.Tuberculosis (Edinb). 2013 May;93(3):343-56. doi: 10.1016/j.tube.2013.02.011. Epub 2013 Mar 13. Tuberculosis (Edinb). 2013. PMID: 23491716 Free PMC article.
-
Small Animal Models for Human Immunodeficiency Virus (HIV), Hepatitis B, and Tuberculosis: Proceedings of an NIAID Workshop.Curr HIV Res. 2020;18(1):19-28. doi: 10.2174/1570162X18666191223114019. Curr HIV Res. 2020. PMID: 31870268 Free PMC article.
-
Genomic Analysis of Mycobacterium tuberculosis Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia.Antibiotics (Basel). 2023 Jun 29;12(7):1126. doi: 10.3390/antibiotics12071126. Antibiotics (Basel). 2023. PMID: 37508222 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical